TABLE 3.
Combined cohort | Era 1 (January 1, 2000-September 14, 2004) | Era 2 (September 15, 2004-September 30, 2015) | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
Outcome | Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value |
CNS Dysfunction | 1.08a | 1.05, 1.11 | <0.001 | 1.10 | 0.99, 1.22 | 0.08 | 1.08a | 1.04, 1.11 | <0.001 |
PNS 1: Symptoms | 1.09 | 1.07, 1.11 | <0.001 | 1.10 | 1.04, 1.17 | <0.001 | 1.08 | 1.06, 1.10 | <0.001 |
PNS 2: Symptoms + PN | - | - | - | 1.23a | 0.83, 1.83 | 0.31 | 1.15a | 1.03, 1.28 | 0.01 |
PNS 3: Symptoms + EPT | - | - | - | 1.00a | 0.88, 1.14 | 0.97 | 1.12 | 1.06, 1.19 | <0.001 |
PNS 4: Symptoms + PN + EPT | - | - | - | 1.04a | 0.61, 1.76 | 0.89 | 1.25a | 1.03, 1.52 | 0.03 |
Note: In combined cohort, Cox proportional-hazards regression analysis was only conducted for CNS dysfunction outcome and PNS symptoms outcome.
Abbreviations: CNS, central nervous system; EPT, electrophysiological testing; PN, peripheral neuropathy; PNS, peripheral nervous system.
Proportional hazards assumption failed and categorical time-varying analysis was performed (Table S8).